Background. Dedifferentiated chondrosarcomas (DDCSs) are highly malignant tumors with
a dismal prognosis and present a significant challenge in clinical management. Methods. In …

Simple Summary Dedifferentiated chondrosarcoma (DDCS) is a rare cancer that is
aggressive and leads to high patient mortality. There are limited data on the efficacy of …

Introduction The role of chemotherapy for patients with dedifferentiated chondrosarcoma
(DDCS) is still under discussion. Here, we present the outcome in patients with DDCS …

Background Dedifferentiated chondrosarcoma (DCS) is a rare and aggressive malignancy
with a poor prognosis. The purpose of this investigation was to describe our treatment and …

Background: Dedifferentiated chondrosarcoma (DDC) accounts for a small proportion of
chondrosarcomas. They demonstrate aggressive behaviour with a high rate of local …

Background and Objectives Dedifferentiated chondrosarcoma is a rare malignancy with
reported 5‐year overall survival rates ranging from 7% to 24%. The purpose of this …

Background Dedifferentiated chondrosarcomas consist of two distinguishable components:
low-grade chondrosarcoma components and high-grade dedifferentiated components …

Chondrosarcoma is the second most common primary malignant bone tumor. In this
multicenter study, we sought to evaluate the disease‐specific survival (DSS) and disease …

Abstract Purpose of Review The pathogenesis of dedifferentiated chondrosarcoma is
controversial, and no genetic abnormality has consistently been identified in the disease …

Background Dedifferentiated chondrosarcoma is a rare, highly malignant tumor with a poor
survival. There are many confusing issues concerning the imaging feature that can facilitate …